Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $32.31M | $78.12M | -58.64% |
Operating Income | $-251.15M | $-169.18M | -48.45% |
Net Income | $-237.09M | $-153.22M | -54.74% |
EPS (Basic) | $-2.88 | $-2.02 | -42.57% |
EPS (Diluted) | $-2.88 | $-2.02 | -42.57% |
R&D Expense | $199.25M | $177.65M | +12.16% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $341.59M | $499.15M | -31.57% |
Current Assets | $289.31M | $340.83M | -15.11% |
Total Liabilities | $207.31M | $150.06M | +38.16% |
Current Liabilities | $77.22M | $63.22M | +22.16% |
Stockholders' Equity | $134.27M | $349.1M | -61.54% |
Cash & Equivalents | $131.54M | $123.65M | +6.38% |
Long-Term Debt | $57.43M | — | — |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-210.28M | $-132.18M | -59.09% |
Investing Cash Flow | $162.15M | $-3.73M | +4445.91% |
Financing Cash Flow | $56.03M | $118.04M | -52.54% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -777.2% | -216.6% | -560.67% |
Net Margin | -733.7% | — | — |
ROE | -176.6% | — | — |
ROA | -69.4% | — | — |
Current Ratio | $3.746 | — | — |
Debt to Equity | $1.544 | — | — |
Other companies in Biotechnology